PHX Panhandle Royalty Company gains 15% Sep 29, 2017

Panhandle Oil and Gas Inc. acquires, develops, and manages oil and natural gas properties in the United States. The company produces and sells natural gas, crude oil, and natural gas liquids. Its mineral and leasehold properties are located in Arkansas, New Mexico, North Dakota, Oklahoma, and Texas. As of September 30, 2016, the company owned 255,019 net mineral acres; leased 19,532 net acres; and held working and royalty interests in 6,233 producing oil and natural gas wells, as well as 45 wells in the process of being drilled or completed. It serves pipeline and marketing companies. Panhandle Oil and Gas Inc. was founded in 1926 and is based in Oklahoma City, Oklahoma. http://www.priceseries.com/trade/PHX-Panhandle-Royalty-Company-stock-gains-15-percent-a-Trade-Record-by-priceSeries-2017082920170929.html

NH NantHealth Inc gains 35% Sep 29, 2017

NantHealth, Inc., a transformational healthcare cloud-based IT company, provides cloud-based platform solutions that converge science and technology through integrated clinical platform to provide actionable health information at the point of care for critical illnesses. The company develops an adaptive learning system, CLINICS, which includes software, middleware, and hardware systems infrastructure that collects, indexes, analyzes, and interprets molecular, clinical, operational, and financial data points derived from novel and traditional sources, and enhance decision-making. Its systems infrastructure includes software, middleware and hardware modules, and NantOS, which organize and integrate the data streams for its adaptive learning system; and NantOS apps and app suites that are designed to enable the delivery of the medicine to patient. The company was formerly known as Nant Health, LLC and changed its name to NantHealth, Inc. in June 2016. The company was founded in 2010 and is headquartered in Culver City, California. NantHealth, Inc. operates as a subsidiary of NantWorks, LLC. http://www.priceseries.com/trade/NH-NantHealth-Inc-stock-gains-35-percent-a-Trade-Record-by-priceSeries-2017090520170929.html

MRIN Marin Software Incorporated gains 52% Sep 29, 2017

Marin Software Incorporated operates a cross-channel advertising cloud platform in the United States and internationally. Its platform allows marketing professionals to manage their digital advertising spend across search, social, and display channels. The company's platform consists of various modules, including Optimization module that helps advertisers to manage bids across publishers to meet revenue goals and identify opportunities for campaign improvements; Reporting and Analytics module that enables advertisers to report results at a business level and analyze cross-channel performance trends; and Campaign Management module, which provides the digital advertiser with an interface to create, manage, and optimize campaigns across various publishers. It also offers Connect module that enables advertisers to automate and streamline the capture of revenue, cost, and audience data from a range of sources, such as ad servers, analytics systems, CRM platforms, publishers, and third party databases. In addition, the company provides Marin Enterprise and Marin Display, which provide digital advertisers to manage large-scale advertising campaigns; Perfect Audience for rapid deployment, as well as to implement and optimize campaigns across various networks and across devices; and Marin Professional that is designed for rapid deployment and offers customers a workflow, analysis, and optimization solution for managing digital advertising. The company markets and sells its solutions to advertisers directly and through advertising agencies that use its platform on behalf of their customers. Marin Software Incorporated was founded in 2006 and is headquartered in San Francisco, California. http://www.priceseries.com/trade/MRIN-Marin-Software-Incorporated-stock-gains-52-percent-a-Trade-Record-by-priceSeries-2017090620170929.html

I Intelsat S.A. gains 19% Sep 29, 2017

Intelsat S.A., through its subsidiaries, provides satellite communications services worldwide. The company offers a range of communications services to media companies, fixed and wireless telecommunications operators, data networking service providers for enterprise and mobile applications in the air and on the seas, multinational corporations, and ISPs; and commercial satellite communication services to the U.S. government and other military organizations and their contractors. It provides various on-network services, including transponder services; managed services that combine satellite capacity, teleport facilities, satellite communications hardware, and other ground facilities to provide managed and monitored broadband, trunking, video, and private network services to customers; and channel services primarily used for point-to-point bilateral services to telecommunications providers. The company also offers off-network and other services comprising transponder, mobile satellite, and other services. In addition, it offers satellite-related consulting and technical services that include the lifecycle of satellite operations and related infrastructure, from satellite and launch vehicle procurement through telemetry and commanding services, and related equipment sale services to other satellite operators. The company was founded in 1964 and is headquartered in Luxembourg, Luxembourg. Intelsat S.A. is a subsidiary of Serafina S.A. http://www.priceseries.com/trade/I-Intelsat-SA-stock-gains-19-percent-a-Trade-Record-by-priceSeries-2017091120170929.html

SAEX SAExploration Holdings, Inc. gains 44% Sep 28, 2017

SAExploration Holdings, Inc., an oilfield services company, provides seismic data acquisition and logistical support services to the oil and gas industry in North and South America, and Southeast Asia. Its seismic data acquisition services include program design, planning and permitting, camp services, survey, drilling, recording, reclamation, and in-field processing. The company acquires 2D, 3D, time-lapse 4D, and multi-component seismic data on land, in transition zones between land and water, and in offshore in depths reaching 3,000 meters. It operates crews that utilize approximately 29,500 channels of land and marine seismic data acquisition equipment and other equipment. The company is headquartered in Houston, Texas. http://www.priceseries.com/trade/SAEX-SAExploration-Holdings-Inc-stock-gains-44-percent-a-Trade-Record-by-priceSeries-2017090720170928.html

RGLS Regulus Therapeutics Inc. gains 28% Sep 28, 2017

Regulus Therapeutics Inc., a biopharmaceutical company, focuses on the discovery and development of drugs that target microRNAs to treat a range of diseases in the United States. The company uses its microRNA product platform to develop anti-miRs, which are chemically modified and single-stranded oligonucleotides. Its clinical development products include RG-101, a GalNAc-conjugated anti-miR targeting miR-122 to treat patients with hepatitis C virus infection; RG-012, an anti-miR targeting microRNA-21 for the treatment of Alport syndrome; RG-125, a GalNAc-conjugated anti-miR targeting microRNA-103/107 for the treatment of non-alcoholic fatty liver disease; RGLS5040, an anti-miR targeting microRNA-27 for the treatment of cholestatic disease; and RGLS4326, an anti-miR targeting microRNA-17 for the treatment of autosomal dominant polycystic kidney disease. The company has strategic alliance with AstraZeneca AB and Sanofi to discover, develop, and commercialize microRNA therapeutics; and Biogen Inc. on microRNA biomarkers for multiple sclerosis, as well as a clinical trial collaboration agreement with GSK LLC. Regulus Therapeutics Inc. was founded in 2007 and is headquartered in San Diego, California. http://www.priceseries.com/trade/RGLS-Regulus-Therapeutics-Inc-stock-gains-28-percent-a-Trade-Record-by-priceSeries-2017090620170928.html

PNTR Pointer Telocation Ltd. gains 40% Sep 28, 2017

Pointer Telocation Ltd. provides mobile resource management (MRM) products and services for the automotive, insurance industries, and other mobile tracking markets worldwide. It operates in three segments: Cellocator, MRM, and Roadside Assistance (RSA). The Cellocator segment designs, develops, and manufactures MRM products comprising asset tracking; fleet management; and stolen vehicle retrieval (SVR) products consisting of remote monitoring and control solutions, such as installation in vehicles, command and control center products, and communication infrastructure products. The MRM segment offers asset tracking, fleet management, SVR, and car sharing services. The RSA segment provides roadside assistance services, such as towing services, temporary vehicle replacement services, and mobile automobile repair services, as well as vehicle body work and replacement parts installation services; and emergency home repair and other services, such as household plumbing repair services for insurance companies, including installation, water damage repair, and replacement of water heaters. The company was formerly known as Nexus Telocation Systems Ltd. and changed its name to Pointer Telocation Ltd. in January 2006. Pointer Telocation Ltd. was founded in 1991 and is headquartered in Rosh Haayin, Israel. http://www.priceseries.com/trade/PNTR-Pointer-Telocation-Ltd-stock-gains-40-percent-a-Trade-Record-by-priceSeries-2017081420170928.html

LXU Lsb Industries Inc. gains 17% Sep 28, 2017

LSB Industries, Inc. manufactures and sells chemical products for the agricultural, mining, and industrial markets in the United States and internationally. The company provides nitrogen-based fertilizers, such as ammonia, fertilizer grade ammonium nitrate (AN), urea ammonia nitrate, and AN ammonia solution for agricultural applications; high purity and commercial grade ammonia, high purity AN, sulfuric acids, mixed nitrating acids, carbon dioxide, and diesel exhaust fluids, as well as concentrated, blended, and regular nitric acids for industrial applications; and industrial grade AN and solutions for the mining industry. It offers industrial acids and other chemical products to the polyurethane, paper, fiber, emission control, and electronic industries; and blended and regular nitric acids, and industrial and high purity ammonia for various specialty applications, including the reduction of air emissions from power plants, as well as agricultural products to farmers, ranchers, fertilizer dealers, and distributors. The company also sells industrial machinery and related components; and holds working interests in natural gas properties. LSB Industries, Inc. was founded in 1968 and is headquartered in Oklahoma City, Oklahoma. http://www.priceseries.com/trade/LXU-Lsb-Industries-Inc-stock-gains-17-percent-a-Trade-Record-by-priceSeries-2017091120170928.html

HOS Hornbeck Offshore Services gains 26% Sep 28, 2017

Hornbeck Offshore Services, Inc., together with its subsidiaries, provides marine transportation, subsea installation, and accommodation support services to exploration and production, oilfield service, offshore construction, and the U.S. military customers. It operates offshore supply vessels (OSVs), multi-purpose support vessels (MPSVs), and a shore-based facility to provide logistics support and specialty services to the offshore oil and gas exploration and production industry, primarily in the U.S. Gulf of Mexico, Latin America, and internationally. Its fleet of U.S.-flagged OSVs and MPSVs support deep-well, deepwater, and ultra-deepwater activities of the offshore oil and gas industry, such as oil and gas exploration, field development, production, construction, installation, well-stimulation, and other enhanced oil recovery, as well as inspection, repair, and maintenance services. The company also provides vessel management services, including crewing, daily operational management, and maintenance activities for other vessels owners. As of February 15, 2017, it owned and operated 62 OSVs and 8 MPSVs. Hornbeck Offshore Services, Inc. was founded in 1997 and is headquartered in Covington, Louisiana. http://www.priceseries.com/trade/HOS-Hornbeck-Offshore-Services-stock-gains-26-percent-a-Trade-Record-by-priceSeries-2017090820170928.html

EMES Emerge Energy Services LP gains 33% Sep 28, 2017

Emerge Energy Services LP acquires, owns, operates, and develops a portfolio of energy service assets in the United States. The company operates in two segments, Sand and Fuel. The Sand segment is involved in the production and sale of various grades of industrial sand primarily used in the extraction of oil and natural gas, as well as in the production of building products and foundry materials. The Fuel segment operates two terminals and two transmix processing facilities located in the Dallas-Fort Worth, Texas area, as well as in Birmingham, Alabama. This segment also engages in the sale of wholesale petroleum products; provision of third-party terminaling services; blending of renewable fuels into petroleum products; manufacture of biodiesel; and provision of reclamation services, such as tank cleaning services, as well as other complementary products and services. Emerge Energy Services GP, LLC operates as a general partner of the company. Emerge Energy Services LP was founded in 2012 and is based in Southlake, Texas. http://www.priceseries.com/trade/EMES-Emerge-Energy-Services-LP-stock-gains-33-percent-a-Trade-Record-by-priceSeries-2017082520170928.html

DPLO Diplomat Pharmacy, Inc. gains 15% Sep 28, 2017

Diplomat Pharmacy, Inc. operates as an independent specialty pharmacy in the United States. The company stocks, dispenses, and distributes prescriptions for various biotechnology and specialty pharmaceutical manufacturers. It also provides specialty infusion pharmacy, patient care coordination, clinical, compliance and persistency program, patient financial assistance, specialty pharmacy training/consulting, benefits investigation, prior authorization, risk evaluation and medication strategy, retail specialty, and hub services, as well as clinical and administrative support services to hospitals and health systems. The company's primary focus is on medication management programs for individuals with complex chronic diseases, including oncology, immunology, hepatitis, multiple sclerosis, specialized infusion therapy, and various other serious or long-term conditions. Diplomat Pharmacy, Inc. has 19 pharmacy locations in Arizona, California, Connecticut, Florida, Illinois, Iowa, Maryland, Massachusetts, Michigan, Minnesota, North Carolina, Ohio, Pennsylvania, and Texas. The company was founded in 1975 and is headquartered in Flint, Michigan. http://www.priceseries.com/trade/DPLO-Diplomat-Pharmacy-Inc-stock-gains-15-percent-a-Trade-Record-by-priceSeries-2017090820170928.html

BLDP Ballard Power Systems, Inc. gains 58% Sep 28, 2017

Ballard Power Systems Inc. engages in the development and commercialization of proton exchange membrane fuel cells worldwide. It is primarily involved in the design, development, manufacture, sale, and service of fuel cell stacks, modules, and systems for various applications. The company also develops methanol clean energy backup power systems, as well as provides engineering services for various fuel cell applications. Ballard Power Systems Inc. offers its fuel cell products for various applications, including portable power, material handling, and telecom backup power, as well as power product markets of bus and tram applications. The company has a strategic alliance with Zhongshan Broad-Ocean Motor Company Limited to produce fuel cell modules for use in buses and commercial vehicles in various cities and regions in China. Ballard Power Systems Inc. was founded in 1979 and is headquartered in Burnaby, Canada. http://www.priceseries.com/trade/BLDP-Ballard-Power-Systems-Inc-stock-gains-58-percent-a-Trade-Record-by-priceSeries-2017083020170928.html

AKTX Akari Therapeutics Plc gains 66% Sep 28, 2017

As of September 18, 2015, Celsus Therapeutics Plc was acquired by Akari Therapeutics, Plc, in a reverse merger transaction. Celsus Therapeutics Plc, a development stage biopharmaceutical company, engages in the discovery and development of non-ste... http://www.priceseries.com/trade/AKTX-Akari-Therapeutics-Plc-stock-gains-66-percent-a-Trade-Record-by-priceSeries-2017090820170928.html

ACTG Acacia Research Corporation gains 28% Sep 28, 2017

Acacia Research Corporation, through its subsidiaries, invests in, develops, licenses, and enforces patented technologies in the United States. It assists patent owners with the prosecution and development of their patent portfolios; the protection of their patented inventions from unauthorized use; the generation of licensing revenue from users of their patented technologies; and enforcement against unauthorized users of their patented technologies through the filing of patent infringement litigation. The company owns or controls the rights to various patent portfolios, which include the United States' patents and foreign counterparts covering technologies used in various industries. It has approximately 1,530 license agreements and 192 patent portfolio licensing and enforcement programs. Acacia Research Corporation was founded in 1992 and is headquartered in Newport Beach, California. http://www.priceseries.com/trade/ACTG-Acacia-Research-Corporation-stock-gains-28-percent-a-Trade-Record-by-priceSeries-2017090720170928.html

VNET 21Vianet Group, Inc. gains 27% Sep 27, 2017

21Vianet Group, Inc. provides carrier-neutral Internet data center services to Internet companies, government entities, blue-chip enterprises, and small-to mid-sized enterprises in the People's Republic of China. It offers hosting and related services to house servers and networking equipment in its data centers, and connects them through a data transmission network; and other hosting related value-added services. Its hosting and related services include managed hosting services that offer data center space to customers' servers and networking equipment and provide tailored server administration services; and interconnectivity services that enable customers to connect their servers with Internet backbones and other networks through its border gateway protocol network or single-line, dual-line, or multiple-line network. Its hosting and related services also comprise content delivery network services that optimize the speed and security of data transmission; cloud services that enable businesses to run their applications over the Internet using its IT infrastructure; virtual private network services; and other value-added services, such as firewall, server load balancing, data backup and recovery, data center management, server management, and backup server services. In addition, the company provides traffic charts and analysis, gateway monitoring for servers, domain name system setup, defense mechanism against distributed denial of service attacks, basic setting of switches and routers, and virus protections; and managed network services consisting of hosting area network, route optimization, and last-mile wired broadband services. As of December 31, 2015, it operated 16 self-built and 69 partnered data centers located in approximately 30 cities in China with 23,556 cabinets. It has strategic partnerships with Microsoft Corporation and IBM. The company was founded in 1999 and is headquartered in Beijing, the People's Republic of China. http://www.priceseries.com/trade/VNET-21Vianet-Group-Inc-stock-gains-27-percent-a-Trade-Record-by-priceSeries-2017082520170927.html

VET Vermilion Energy Inc. gains 15% Sep 27, 2017

Vermilion Energy Inc. acquires, explores, develops, and produces crude oil and natural gas in North America, Europe, and Australia. As of December 31, 2016, it owned 74% interest in 328,500 net acres of developed land and 89% interest in 500,300 net acres of undeveloped land, as well as 358 net producing natural gas wells and 445 net producing oil wells in Canada; and 96% interest in 208,900 net acres of developed land and 100% interest in 336,600 net acres of undeveloped land in the Aquitaine and Paris Basins, as well as 331 net producing oil wells in France. The company also owned 56% interest in 841,500 net acres of land, as well as 37 net producing gas wells in the Netherlands; 25,800 net acres of developed and 1,054,900 net acres of undeveloped land, as well as 111 net producing oil wells and 7 net producing natural gas wells in Germany; and 97,200 net acres of land and 9 net producing oil wells in the United States. In addition, it holds 18.5% interest in the offshore Corrib gas field in Ireland; and 100% interest in the Wandoo block that consists of 59,600 acres located in Australia. Further, the company has 77,092 barrels of oil equivalent (Mboe) of total proved reserves and 130,215 Mboe of proved plus probable reserves located in Canada; 42,958 Mboe of total proved reserves and 65,040 Mboe of proved plus probable reserves situated in France; 10,473 Mboe of total proved reserves and 17,733 Mboe of proved plus probable reserves located in the Netherlands; 12,202 Mboe of total proved reserves and 23,528 Mboe of proved plus probable reserves situated in Germany; 16,596 Mboe of total proved reserves and 25,061 Mboe of proved plus probable reserves located in Ireland; 12,418 Mboe of total proved reserves and 17,068 Mboe of proved plus probable reserves located in Australia; and 4,076 Mboe of total proved reserves and 11,477 Mboe of proved plus probable reserves located in the United States. The company was founded in 1994 and is headquartered in Calgary, Canada. http://www.priceseries.com/trade/VET-Vermilion-Energy-Inc-stock-gains-15-percent-a-Trade-Record-by-priceSeries-2017082920170927.html

TELL Tellurian Inc. gains 20% Sep 27, 2017

Tellurian Investments Inc. offers mid-scale natural gas liquefaction and export projects. The company was incorporated in 2015 and is based in Houston, Texas. http://www.priceseries.com/trade/TELL-Tellurian-Inc-stock-gains-20-percent-a-Trade-Record-by-priceSeries-2017083020170927.html

KONA Kona Grill, Inc. gains 19% Sep 27, 2017

Kona Grill, Inc. owns and operates upscale casual restaurants under the Kona Grill brand name. As of February 27, 2017, it owned and operated 45 restaurants in 23 states of the United States and Puerto Rico. Kona Grill, Inc. is based in Scottsdale, Arizona. http://www.priceseries.com/trade/KONA-Kona-Grill-Inc-stock-gains-19-percent-a-Trade-Record-by-priceSeries-2017091120170927.html

EBIO Eleven Biotherapeutics, Inc. gains 23% Sep 27, 2017

Eleven Biotherapeutics, Inc., a biologic oncology company, focuses on the development of novel therapies based upon tumor targeting antibody fragments genetically fused to a cytotoxic protein payload called Targeted Protein Therapeutics (TPTs). The company's advanced TPTs are in clinical development for cancers, which have significant unmet needs for patients. It is developing Vicinium that is in active Phase 3 clinical trial in the United States and Canada for the treatment of non-muscle invasive bladder cancer; and Proxinium for late stage squamous cell carcinoma of the head and neck, preparing for a Phase 2 clinical trial in combination with cancer immunotherapy. The company was founded in 2008 and is based in Cambridge, Massachusetts. http://www.priceseries.com/trade/EBIO-Eleven-Biotherapeutics-Inc-stock-gains-23-percent-a-Trade-Record-by-priceSeries-2017090720170927.html

BFR BBVA Banco Frances S.A. gains 15% Sep 27, 2017

BBVA Banco Francés S.A., together with its subsidiaries, provides various financial services to corporations, medium and small companies, and individual customers in Spain, Mexico, South America, the United States, and Eurasia. The company offers checking and savings accounts, time deposits, and trading and investment accounts. It also provides loans to the public sector, loans to local financial institutions, and short-term loans to companies, as well as overdraft lines of credit, discounted instruments, real estate mortgage loans, collateral loans, consumer loans, credit card loans, and short-term placements in foreign banks. In addition, the company offers fire, household, civil liability, theft, personal accidents, group life, and other insurance coverage products; payroll management services; investment fund and pension management services; stock exchange brokerage; and insurance advisory services to customers in the areas of coverage of risks related to life, personal accidents, as well as home and automatic teller machines (ATMs) robbery insurance. Further, it provides portfolio and asset management; foreign trade services, including letters of credit, collections, bank drafts, fund transfers, and foreign currency transactions; and electronic banking and trust services, as well as issues and trades in commercial papers, corporate bonds, trust bonds, other credit instruments, and futures and options. As of December 31, 2015, it operated through a network of 285 attention-to-clients units; 14 in-company branches; 1 points of sale; and other distribution channels, such as 694 ATMs, 797 self-service terminals, a telephone banking, and an Internet banking service. The company was formerly known as Banco Francés S.A. and changed its name to BBVA Banco Francés S.A. in October 2000. The company was founded in 1886 and is headquartered in Buenos Aires, the Republic of Argentina. BBVA Banco Francés S.A. is a subsidiary of Banco Bilbao Vizcaya Argentaria S.A. http://www.priceseries.com/trade/BFR-BBVA-Banco-Frances-SA-stock-gains-15-percent-a-Trade-Record-by-priceSeries-2017082220170927.html

RH Restoration Hardware Holdings Inc. gains 42% Sep 26, 2017

RH, together with its subsidiaries, engages in the retail of home furnishings. It offers products in various categories, such as furniture, lighting, textiles, bathware, decor, outdoor and garden, tableware, and child and teen furnishings. The company sells products through its stores and catalogs, as well as through its Websites, such as restorationhardware.com, rh.com, rhbabyandchild.com, rhteen.com, and rhmodern.com. As of October 29, 2016, it operated 85 retail galleries that include 51 legacy galleries, 6 larger format design galleries, 7 next generation design galleries, 1 RH modern gallery, and 5 RH baby & child galleries throughout the United States and Canada; 15 Waterworks showrooms in the United States and the United Kingdom; and 28 outlet stores. The company was formerly known as Restoration Hardware Holdings, Inc. and changed its name to RH in January 2017. RH was founded in 1979 and is headquartered in Corte Madera, California. http://www.priceseries.com/trade/RH-Restoration-Hardware-Holdings-Inc-stock-gains-42-percent-a-Trade-Record-by-priceSeries-2017090120170926.html

PII Polaris Industries Inc. gains 17% Sep 26, 2017

Polaris Industries Inc. designs, engineers, manufactures, and markets power sports vehicles worldwide. It operates through four segments: Off-Road Vehicles (ORVs)/Snowmobiles, Motorcycles, Global Adjacent Markets, and Other. The company provides ORVs, including all-terrain vehicles and side-by-side vehicles for recreational, military, and utility use; snowmobiles and technical riding gears; three-wheel motorcycles; and low emission, light duty hauling, passenger, commercial, and industrial vehicles. It also produces or supplies various replacement parts and accessories consisting of winches, bumpers/brush guards, plows, racks, wheels, mowers, tires, lighting and audio systems, pull-behinds, cabs systems, cargo box accessories, tracks, and oils for ORVs; covers, traction products, reverse kits, electric starters, tracks, bags, windshields, oils, and lubricants for snowmobiles; and saddle bags, handlebars, backrests, exhausts, windshields, seats, oils, and various chrome accessories for motorcycles. In addition, the company sells recreational apparel, such as helmets, jackets, pants, hats, goggles, gloves, boots, bibs, and leathers through a network of independent dealers and distributors, as well as through online. Polaris Industries Inc. markets its products under the GEM, Goupil, Aixam, Taylor-Dunn, Klim, Timbersled, Indian Motorcycle, and kolpin brands, as well as under the BRUTUS, RZR, RANGER, GENERAL, Sportsman, Polaris ACE, RIDE COMMAND, Pro Armor, AXYS, DAGOR, Sportsman MV, MRZR, and Slingshot names. Further, it manufactures, distributes, retails, and installs aftermarket parts and accessories for light trucks, jeeps, sport-utility vehicles, and other four-wheel drive vehicles under the Pro Comp, Smittybilt, Rubicon Express, Poison Spyder, Trail Master, LRG, and G2 Axle & Gear brands through its stores, call centers, and e-commerce sites. Polaris Industries Inc. was founded in 1954 and is headquartered in Medina, Minnesota. http://www.priceseries.com/trade/PII-Polaris-Industries-Inc-stock-gains-17-percent-a-Trade-Record-by-priceSeries-2017082120170926.html

NTLA Intellia Therapeutics Inc gains 40% Sep 26, 2017

Intellia Therapeutics Inc., a gene editing company, focuses on the development of therapeutics utilizing a biological tool known as the CRISPR/Cas9 system. The company develops in vivo programs focused on liver diseases, including transthyretin amyloidosis, alpha-1 antitrypsin deficiency, hepatitis B virus, and inborn errors of metabolism; and ex vivo applications of the technology in chimeric antigen receptor T cell and hematopoietic stem cell product candidates. It has a strategic collaboration and license agreement with Novartis focused on the development of new ex vivo CRISPR/Cas9-based therapies. Intellia Therapeutics Inc. was formerly known as AZRN, Inc. and changed its name to Intellia Therapeutics Inc. in July 2014. The company was founded in 2014 and is headquartered in Cambridge, Massachusetts. http://www.priceseries.com/trade/NTLA-Intellia-Therapeutics-Inc-stock-gains-40-percent-a-Trade-Record-by-priceSeries-2017082120170926.html

EVOK Evoke Pharma, Inc. gains 22% Sep 26, 2017

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development of drugs for the treatment of gastroenterological disorders and diseases. The company develops EVK-001, a metoclopramide nasal spray, which is in Phase III clinical trials for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Evoke Pharma, Inc. was founded in 2007 and is headquartered in Solana Beach, California. http://www.priceseries.com/trade/EVOK-Evoke-Pharma-Inc-stock-gains-22-percent-a-Trade-Record-by-priceSeries-2017090120170926.html

DVAX Dynavax Technologies Corporation gains 19% Sep 26, 2017

Dynavax Technologies Corporation, a clinical-stage immunotherapy company, focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor (TLR) stimulation. Its product candidates are being investigated for use in multiple cancer indications, as a vaccine for the prevention of hepatitis B and as a disease modifying therapy for asthma. The company's lead product candidates include HEPLISAV-B, an investigational adult hepatitis B vaccine, which is in Phase III clinical trials; and SD-101, an investigational cancer immunotherapeutic that is in Phase I/II studies. Its product candidates also comprise AZD1419, which is in Phase II clinical trial for the treatment of asthma; DV230F that is in preclinical stage for the treatment of liver tumors; and DV1001, a TLR 7&8 agonist, which is in preclinical stage for the treatment of for multiple malignancies, as well as DV281 for the treatment of non-small cell lung cancer. It has collaboration and license agreements with AstraZeneca AB to develop AZD1419 for the treatment of asthma; and Merck & Co. to develop SD-101 for varios immuno-oncology therapies. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was founded in 1996 and is headquartered in Berkeley, California. http://www.priceseries.com/trade/DVAX-Dynavax-Technologies-Corporation-stock-gains-19-percent-a-Trade-Record-by-priceSeries-2017083020170926.html

ALDX Aldeyra Therapeutics, Inc. gains 32% Sep 26, 2017

Aldeyra Therapeutics, Inc., a biotechnology company, focuses on the development of products for diseases caused by inflammation and inborn errors of metabolism in the United States and internationally. It is developing NS2, a small molecule designed to trap and allow for the degradation of aldehydes. Its product is used for the treatment of allergic conjunctivitis, noninfectious anterior uveitis, sjögren-larsson syndrome, and succinic semi-aldehyde dehydrogenase deficiency. The company was formerly known as Aldexa Therapeutics, Inc. and changed its name to Aldeyra Therapeutics, Inc. in March 2014. Aldeyra Therapeutics, Inc. was founded in 2004 and is based in Lexington, Massachusetts. http://www.priceseries.com/trade/ALDX-Aldeyra-Therapeutics-Inc-stock-gains-32-percent-a-Trade-Record-by-priceSeries-2017091220170926.html

AGLE Aeglea Biotherapeutics, Inc. gains 48% Sep 26, 2017

Aeglea Biotherapeutics, Inc., a biopharmaceutical company, engages in developing engineered human enzymes for the treatment of inborn errors of metabolism and cancer. It develops AERase/AEB1102, an amino acid for the degradation of arginine in the circulation, as well as for the treatment of hyperargininemia and cancer; and AECase/AEB3103, an engineered and PEGylated human cysteine/cystine degrading enzyme that increases oxidative stress through glutathione depletion for treatment of hematologic and solid malignancies. The company also engages in developing AEMase/AEB2109, an engineered human enzyme that degrades methionine for the treatment of solid tumors; and AEB4104, an engineered human enzyme that degrades homocysteine in the circulation for the treatment of inborn error of metabolism homocystinuria. It has a strategic partnership with KBI Biopharma. Aeglea Biotherapeutics, Inc. was formerly known as Aeglea BioTherapeutics Holdings, LLC. The company was founded in 2013 and is based in Austin, Texas. http://www.priceseries.com/trade/AGLE-Aeglea-Biotherapeutics-Inc-stock-gains-48-percent-a-Trade-Record-by-priceSeries-2017082420170926.html

ABBV AbbVie Inc. gains 18% Sep 26, 2017

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company offers HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; IMBRUVICA, an oral therapy for the treatment of patients with chronic lymphocytic leukemia; and VIEKIRA PAK, an interferon-free therapy, with or without ribavirin, for the treatment of adults with genotype 1 chronic hepatitis C. It also provides Kaletra, an anti- human immunodeficiency virus(HIV)-1 medicine used with other anti-HIV-1 medications as a treatment that maintains viral suppression in HIV-1 patients; Norvir, a protease inhibitor indicated in combination with other antiretroviral agents to treat HIV-1; and Synagis to prevent RSV infection at-risk infants. In addition, the company offers AndroGel, a testosterone replacement therapy for males diagnosed with symptomatic low testosterone; Creon, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid to treat hypothyroidism; and Lupron, a product for the palliative treatment of prostate cancer, endometriosis, and central precocious puberty, as well as for the treatment of patients with anemia. Further, it provides Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Sevoflurane, an anesthesia product for human use; and ZINBRYTA, a subcutaneous treatment for relapsing forms of multiple sclerosis. The company sells its products to wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers from its distribution centers and public warehouses. AbbVie Inc. has collaboration agreements with C2N Diagnostics; Calico Life Sciences LLC; and Infinity Pharmaceuticals, Inc. The company was incorporated in 2012 and is based in North Chicago, Illinois. http://www.priceseries.com/trade/ABBV-AbbVie-Inc-stock-gains-18-percent-a-Trade-Record-by-priceSeries-2017082420170926.html

PBYI Puma Biotechnology Inc gains 23% Sep 25, 2017

Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to improve cancer care. Its drug candidates include PB272 (neratinib (oral)) for the treatment of early stage breast cancer, metastatic breast cancer, non-small cell lung cancer, HER2 mutation-positive solid tumors, and HER2-mutated non-amplified breast cancer; and PB272 (neratinib (intravenous)). The company also develops PB357, an orally administered agent that is an irreversible tyrosine kinase inhibitor that blocks signal transduction through the epidermal growth factor receptors, HER1, HER2, and HER4. It has a license agreement with Pfizer, Inc. for the development, manufacture, and commercialization of PB272 neratinib (oral), PB272 neratinib (intravenous), PB357, and certain related compounds. Puma Biotechnology, Inc. was founded in 2010 and is headquartered in Los Angeles, California. http://www.priceseries.com/trade/PBYI-Puma-Biotechnology-Inc-stock-gains-23-percent-a-Trade-Record-by-priceSeries-2017082520170925.html

NAK Northern Dynasty Minerals, Ltd. gains 23% Sep 25, 2017

Northern Dynasty Minerals Ltd. engages in the exploration and development of mineral properties in the United States. Its principal property is the Pebble copper-gold-molybdenum mineral project located in southwest Alaska. The company was formerly known as Northern Dynasty Explorations Ltd. and changed its name to Northern Dynasty Minerals Ltd. in October 1997. Northern Dynasty Minerals Ltd. was founded in 1983 and is headquartered in Vancouver, Canada. http://www.priceseries.com/trade/NAK-Northern-Dynasty-Minerals-Ltd-stock-gains-23-percent-a-Trade-Record-by-priceSeries-2017082120170925.html

MU Micron Technology, Inc. gains 15% Sep 25, 2017

Micron Technology, Inc. provides semiconductor systems worldwide. The company operates through four segments: Compute and Networking Business Unit, Storage Business Unit, Mobile Business Unit, and Embedded Business Unit. It offers DDR3 and DDR4 DRAM products for computers, servers, networking devices, communications equipment, consumer electronics, automotive, and industrial applications; mobile low-power DRAM products for smartphones, tablets, automotive, laptop computers, and other mobile consumer device applications; DDR2 and DDR DRAM, GDDR5 and GDDR5X DRAM, SDRAM, and RLDRAM products for networking devices, servers, consumer electronics, communications equipment, computer peripherals, automotive and industrial applications, and computer memory upgrades; and hybrid memory cube semiconductor memory devices for use in networking and computing applications. The company also provides NAND Flash products, which are electrically re-writeable, non-volatile semiconductor memory devices; client solid-state drives (SSDs) for notebooks, desktops, workstations, and other consumer applications; enterprise SSDs for server and storage applications; managed multi-chip package products; digital media products, including flash memory cards and JumpDrive products under the Lexar brand name. In addition, it manufactures products that are sold under other brand names; and resells flash memory products that are purchased from other NAND Flash suppliers. Further, the company provides 3D XPoint memory products; and NOR Flash, which are electrically re-writeable and semiconductor memory devices for automotive, industrial, connected home, and consumer applications. It markets its products to original equipment manufacturers and retailers through its internal sales force, independent sales representatives, and distributors; and through a Web-based customer direct sales channel, and channel and distribution partners. The company was founded in 1978 and is headquartered in Boise, Idaho. http://www.priceseries.com/trade/MU-Micron-Technology-Inc-stock-gains-15-percent-a-Trade-Record-by-priceSeries-2017082520170925.html

MTCH Match Group, Inc. gains 21% Sep 25, 2017

Match Group, Inc. provides dating products. The company operates in two segments, Dating and Non-dating. It operates a portfolio of approximately 45 brands, including Match, OkCupid, PlentyOfFish, Tinder, Meetic, Twoo, OurTime, BlackPeopleMeet, and FriendScout24. The company offers its dating products through its Websites and applications in 38 languages approximately in 190 countries. It also provides various test preparation, academic tutoring, and college counseling services. The company was incorporated in 2009 and is headquartered in Dallas, Texas. Match Group, Inc. operates as a subsidiary of IAC/InterActiveCorp. http://www.priceseries.com/trade/MTCH-Match-Group-Inc-stock-gains-21-percent-a-Trade-Record-by-priceSeries-2017082820170925.html

IO Ion Geophysical Corporation gains 68% Sep 25, 2017

ION Geophysical Corporation provides geoscience products, services, and solutions to the oil and gas industry worldwide. It operates through three segments: E&P Technology & Services, E&P Operations Optimization, and Ocean Bottom Services. The E&P Technology & Services segment offers services to manage the entire seismic process, from survey planning and design to data acquisition and management, to final subsurface imaging and reservoir characterization. This segment also provides data processing and imaging services to help its exploration and production customers for reducing exploration and production risk, evaluating and developing reservoirs, and increase production. The E&P Operations Optimization segment provides command and control software systems, related software and services for towed marine streamer and ocean bottom seismic operations, as well as for survey design. This segment also manufactures and repairs marine towed streamer acquisition and positioning systems, and analog geophone sensors. The Ocean Bottom Services segment offers survey design, planning, and optimization services to maximize seismic image quality, operational efficiency, and safety; superior imaging services; and data processing, interpretation, and reservoir services This segment also manufactures re-deployable ocean bottom cable seismic data acquisition systems. ION Geophysical Corporation markets and sells its services and products through direct sales force and third-party sales representatives. The company was formerly known as Input/Output, Inc. and changed its name to ION Geophysical Corporation in 2007. ION Geophysical Corporation was founded in 1968 and is headquartered in Houston, Texas. http://www.priceseries.com/trade/IO-Ion-Geophysical-Corporation-stock-gains-68-percent-a-Trade-Record-by-priceSeries-2017082120170925.html

BITA Bitauto Holdings Limited gains 16% Sep 25, 2017

Bitauto Holdings Limited provides Internet content and marketing services for the automotive industry in the People's Republic of China. The company operates in three segments: Advertising Business, EP Platform Business, and Digital Marketing Solutions Business. The Advertising Business segment provides advertising services, including new automobile pricing and promotional information, specifications, reviews, and consumer feedback to automakers through its bitauto.com and taoche.com Websites, as well as mobile applications. The EP Platform Business segment provides Web-based and mobile-based integrated digital marketing, customer relationship management (CRM), and automobile listing services to automobile customers in China. This segment's platform enables dealer subscribers to create their own online showrooms, list pricing and promotional information, provide dealer contact information, place advertisements, and manage customer relationships. It also provides automobile transaction, CRM, and online automotive financial platform services to automobile customers. The Digital Marketing Solutions Business segment provides one-stop digital marketing solutions, such as Website creation and maintenance, online public relations, online marketing campaigns, and advertising agent services to automakers. The company also distributes its dealer customers' automobile pricing and promotional information through its partners who provides Internet services. In addition, it provides customer services and training to dealer customers. Bitauto Holdings Limited was founded in 2000 and is headquartered in Beijing, the People's Republic of China. http://www.priceseries.com/trade/BITA-Bitauto-Holdings-Limited-stock-gains-16-percent-a-Trade-Record-by-priceSeries-2017090620170925.html

ADVM Adverum Biotechnologies, Inc. gains 15% Sep 25, 2017

Avalanche Biotechnologies, Inc., a gene therapy company, engages in discovering and developing novel medicines that offer therapeutic benefit to patients suffering from chronic or debilitating disease. It primary focuses on developing AVA-101, which is in a Phase IIa trial for the treatment of wet age-related macular degeneration (AMD). The company is also developing AVA-201, a product candidate for the prevention of wet AMD; AVA-311 that is in preclinical studies for the treatment of juvenile X-linked retinoschisis, a rare genetic disease of the retina with no approved therapy; and AVA-322 and AVA-323 for the treatment of color vision deficiency. Avalanche Biotechnologies, Inc. has a collaboration agreement with Regeneron Pharmaceuticals, Inc. to research, develop, and commercialize gene therapy products. The company was founded in 2006 and is headquartered in Menlo Park, California. http://www.priceseries.com/trade/ADVM-Adverum-Biotechnologies-Inc-stock-gains-15-percent-a-Trade-Record-by-priceSeries-2017090820170925.html

ACH Aluminum Corporation of China Limited gains 21% Sep 25, 2017

Aluminum Corporation of China Limited, together with its subsidiaries, engages in the manufacture and distribution of alumina, and primary aluminum and energy products in China. It operates through Alumina, Primary Aluminum, Energy, and Trading segments. The Alumina segment is involved in the mining and purchasing of bauxite and other raw materials; refining of bauxite into alumina; sale of alumina; and production and sale of chemical alumina and metal gallium. The Primary Aluminum segment procures alumina and other raw materials, supplemental materials, and electricity power; and produces and sells primary aluminum, as well as carbon products, aluminum alloy products, and other aluminum products. The Energy segment engages in the research and development, production, and operation of energy products, including coal mining; generates and sells electricity to regional power grid corporations using thermal power, wind power, and solar power sources; and manufacture of energy related equipment. The Trading segment trades in alumina, primary aluminum, aluminum fabrication products, other non-ferrous metal products, coal products, raw materials, and supplemental materials; and provides logistics and transport services to internal manufacturing plants and external customers. The company also manufactures, acquires, and distributes bauxite mines, limestone ore, aluminum magnesium ore, and related nonferrous metal products. The company was founded in 2001 and is based in Beijing, the People's Republic of China. http://www.priceseries.com/trade/ACH-Aluminum-Corporation-of-China-Limited-stock-gains-21-percent-a-Trade-Record-by-priceSeries-2017082920170925.html

ULH Universal Logistics Holdings Inc gains 18% Sep 22, 2017

Universal Truckload Services, Inc. provides transportation and logistics solutions in the United States, Mexico, Canada, Colombia, Europe, and internationally. http://www.priceseries.com/trade/ULH-Universal-Logistics-Holdings-Inc-stock-gains-18-percent-a-Trade-Record-by-priceSeries-2017082520170922.html

TCON TRACON Pharmaceuticals, Inc. gains 41% Sep 22, 2017

TRACON Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of novel targeted therapeutics for cancer, wet age-related macular degeneration, and fibrotic diseases. Its lead product candidate is TRC105, which is in Phase II clinical trials for oncology indications, including soft tissue sarcoma, renal cell carcinoma, glioblastoma, and hepatocellular carcinoma. The company's other product candidates comprise TRC205, an endoglin antibody that is in preclinical stage for the treatment of fibrotic diseases; and TRC102, a small molecule, which is in clinical development for the treatment of lung cancer and glioblastoma. TRACON Pharmaceuticals, Inc. has collaboration agreements with National Cancer Institute and Santen. The company was formerly known as Lexington Pharmaceuticals, Inc. and changed its name to TRACON Pharmaceuticals, Inc. in March 2005. TRACON Pharmaceuticals, Inc. was founded in 2004 and is headquartered in San Diego, California. http://www.priceseries.com/trade/TCON-TRACON-Pharmaceuticals-Inc-stock-gains-41-percent-a-Trade-Record-by-priceSeries-2017083020170922.html

SRPT Sarepta Therapeutics, Inc. gains 20% Sep 22, 2017

Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare neuromuscular diseases. The company offers EXONDYS 51, a disease-modifying therapy for the treatment of duchenne muscular dystrophy (DMD), which is a rare genetic muscle-wasting disease caused by the absence of dystrophin. It also develops SRP-4045 and SRP-4053, which are exon skipping clinical product candidates for the treatment of DMD. The company has a strategic alliance with Nationwide Children's Hospital for the advancement of microdystrophin gene therapy program under the research and option agreement, as well as Galgt2 gene therapy program under the license agreement; Catabasis Pharmaceuticals, Inc to explore a combination drug treatment approach for DMD under the research collaboration agreement; and Charley's Fund, Inc. to support the development of product candidates using its proprietary exon-skipping technologies under the research agreement. It also has a license agreement with the University of Western Australia for treatment of DMD by inducing the skipping of certain exons; and collaboration and license agreement with Summit (Oxford) Ltd. for the development of ezutromid, an utrophin modulator which is in phase II clinical trials for the treatment of DMD. The company distributes its products through a network of specialty distributors and specialty pharmacies in the United States. Sarepta Therapeutics, Inc. was founded in 1980 and is headquartered in Cambridge, Massachusetts. http://www.priceseries.com/trade/SRPT-Sarepta-Therapeutics-Inc-stock-gains-20-percent-a-Trade-Record-by-priceSeries-2017082820170922.html

SGMO Sangamo BioSciences, Inc. gains 36% Sep 22, 2017

Sangamo Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on translating ground-breaking science into genomic therapies that transform patients' lives using platform technologies in genome editing, gene therapy, gene regulation, and cell therapy. The company's proprietary zinc finger DNA-binding protein (ZFP) technology enables specific genome editing and gene regulation. The ZFPs could be engineered to make ZFP nucleases (ZFNs), proteins that could be used to specifically modify DNA sequences by adding or knocking out specific genes; and ZFP transcription factors (ZFP TFs), proteins that can be used to turn genes on or off. Its therapeutic products include SB-728-T, a ZFN-mediated autologous T-cell product for human immunodeficiency virus and acquired immunodeficiency syndrome (HIV/AIDS), which is in Phase II and Phase I clinical trials; and SB-728-HSPC that is in Phase I/II clinical trials for HIV/AIDS. The company also engages in Phase I/II studies of in vivo genome editing applications of ZFP Therapeutics for hemophilia B, Hemophilia A, and Mucopolysaccharidosis I (MPS) and MPS II, which are lysosomal storage disorder (LSD); proprietary preclinical programs in other LSDs; and research stage programs in certain central nervous system disorders and cancer immunotherapies. It has collaborative partnerships with Biogen Inc. to develop therapeutic genome editing products in hemoglobinopathies; and with Shire International GmbH to develop the preclinical development program in Huntington's disease, as well as license agreement with Sigma-Aldrich Corporation to develop ZFP-based laboratory research reagents and Dow AgroSciences, LLC to modify the genomes or alter protein expression of plant cells, plants, or plant cell cultures. The company was formerly known as Sangamo BioSciences, Inc. and changed its name to Sangamo Therapeutics, Inc. in January 2017. Sangamo Therapeutics, Inc. was founded in 1995 and is headquartered in Richmond, California. http://www.priceseries.com/trade/SGMO-Sangamo-BioSciences-Inc-stock-gains-36-percent-a-Trade-Record-by-priceSeries-2017082220170922.html

QUIK QuickLogic Corporation gains 17% Sep 22, 2017

QuickLogic Corporation, a fabless semiconductor company, develops and markets low power customizable semiconductor and software algorithm solutions for smartphones, wearable devices, tablets, and the Internet-of-Things. The company delivers these solutions through ultra-low power customer programmable System on Chip (SoC) semiconductor solutions, embedded software, and algorithm solutions for always-on voice and sensor processing, and enhanced visual experiences. Its customer specific standard products incorporate its ArcticLink III S, ArcticLink III VX and BX, PolarPro 3, PolarPro II, and Eclipse II solution platforms, as well as packaging, proven system blocks, custom logic, sensor software algorithms, software drivers, and architecture consulting. Its products include pASIC 3, QuickRAM, and QuickPCI. Its solutions integrate multi-core processing, programmable logic, sensor fusion and context aware algorithms, and embedded software. In addition, the company's embedded FPGA (eFPGA) initiative enables SoC designers to implement post-production changes, and enhance revenue by providing hardware programmability to their end customers. The company markets and sells its products to original equipment manufacturers and original design manufacturers through a network of sales managers and distributors in North America, Europe, and Asia. QuickLogic Corporation was founded in 1988 and is headquartered in Sunnyvale, California. http://www.priceseries.com/trade/QUIK-QuickLogic-Corporation-stock-gains-17-percent-a-Trade-Record-by-priceSeries-2017090120170922.html

PDLI PDL BioPharma, Inc. gains 33% Sep 22, 2017

PDL BioPharma, Inc. acquires and manages companies, products, royalty agreements, and debt facilities in the biotech, pharmaceutical, and medical device industries in the United States, Europe, and internationally. The company operates through two segments, Income Generating Assets and Product Sales. The Income Generating Assets segment consists of royalties from issued patents covering the humanization of antibodies, including Avastin, Herceptin, Xolair, Lucentis, Perjeta, Kadcyla, and Tysabri; and notes and other long-term receivables, royalty rights, hybrid notes/royalties receivable, and equity investments in healthcare companies. The Product Sales segment, through its equity and loan investments, manufactures, markets, and sells prescription pharmaceutical products under the Tekturna and Tekturna HCT names in the United States; and Rasilez and Rasilez HCT names internationally for the treatment of hypertension. This segment sells its products primarily to wholesalers. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada. http://www.priceseries.com/trade/PDLI-PDL-BioPharma-Inc-stock-gains-33-percent-a-Trade-Record-by-priceSeries-2017080420170922.html

FGEN FibroGen, Inc gains 17% Sep 22, 2017

FibroGen, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes therapeutic agents to treat serious unmet medical needs in the United States. It is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases (HIF-PHs) that is in Phase III clinical development for the treatment of anemia in chronic kidney disease; Pamrevlumab, a human-monoclonal antibody that inhibits the activity of connective tissue growth factor, which is in Phase II clinical development for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, liver fibrosis, and Duchenne muscular dystrophy; and FG-5200 for the treatment of corneal blindness resulting from partial thickness corneal damage. It has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. The company was incorporated in 1993 and is headquartered in San Francisco, California. http://www.priceseries.com/trade/FGEN-FibroGen-Inc-stock-gains-17-percent-a-Trade-Record-by-priceSeries-2017082820170922.html

ENPH Enphase Energy, Inc. gains 55% Sep 22, 2017

Enphase Energy, Inc., together with its subsidiaries, designs, develops, and sells microinverter systems for residential and commercial markets in the United States and internationally. The company's semiconductor-based microinverter system converts direct current electricity to alternating current (AC) electricity at the individual solar module level. It also offers energy storage systems, including its AC battery; and system monitoring and control services. The company sells its microinverter systems primarily to distributors, as well as directly to large installers through original equipment manufacturers and strategic partners. Enphase Energy, Inc. was founded in 2006 and is headquartered in Petaluma, California. http://www.priceseries.com/trade/ENPH-Enphase-Energy-Inc-stock-gains-55-percent-a-Trade-Record-by-priceSeries-2017082320170922.html

AP Ampco-Pittsburgh Corporation gains 20% Sep 22, 2017

Ampco-Pittsburgh Corporation, together with its subsidiaries, manufactures and sells custom designed engineering products to commercial and industrial users worldwide. It operates in two segments, Forged and Cast Engineered Products, and Air and Liquid Processing. The Forged and Cast Engineered Products segment produces forged hardened steel rolls that are used in cold rolling by producers of steel, aluminum, and other metals; ingot and open die forged products for use in the oil and gas, and the aluminum and plastic extrusion industries; and cast rolls for hot and cold strip mills, medium/heavy section mills, and plate mills in various iron and steel qualities. This segment also offers forged rolls for cluster mills and Z-Hi mills; work rolls for narrow and wide strip and aluminum mills; back-up rolls for narrow strip mills; leveling rolls and shafts; and bearings, bushings, and key and keyless bearing sleeves, as well as provides a range of services, including rebuild of mill spare parts, chock inspection and repair, and onsite inspections and installations. The Air and Liquid Processing segment produces custom-engineered finned tube heat exchange coils and related heat transfer products for various industries, including OEM/commercial, fossil fuel and nuclear power generation, automotive, industrial process, and HVAC; and air handling systems for use in commercial, institutional, and industrial buildings. This segment also provides centrifugal pumps for the refrigeration, power generation, and marine defense industries. Ampco-Pittsburgh Corporation was founded in 1929 and is headquartered in Carnegie, Pennsylvania. http://www.priceseries.com/trade/AP-Ampco-Pittsburgh-Corporation-stock-gains-20-percent-a-Trade-Record-by-priceSeries-2017082920170922.html

ACIU AC Immune Ltd gains 30% Sep 22, 2017

AC Immune SA is a biopharmaceutical company. It is engaged in leveraging its two proprietary technology platforms to discover, design and develop novel, proprietary medicines for treatment of neurodegenerative diseases. http://www.priceseries.com/trade/ACIU-AC-Immune-Ltd-stock-gains-30-percent-a-Trade-Record-by-priceSeries-2017083020170922.html

ABEO Abeona Therapeutics Inc. gains 71% Sep 22, 2017

Abeona Therapeutics Inc. focuses on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare diseases. The company's lead programs are ABO-101 (AAV NAGLU) and ABO-102 (AAV SGSH), adeno-associated virus (AAV)-based gene therapies for Sanfilippo syndrome (MPS IIIB and IIIA). It is also developing ABO-201 (AAV CLN3) gene therapy for juvenile Batten disease (JBD); and ABO-301 (AAV FANCC) for Fanconi anemia (FA) disorder using a novel CRISPR/Cas9-based gene editing approach to gene therapy program for rare blood diseases. In addition, the company is developing rare plasma protein therapies, including PTB-101 SDF Alpha (alpha-1 protease inhibitor) for inherited COPD using its proprietary SDF (Salt Diafiltration) ethanol-free process. Further, it is involved in marketing MuGard, a mucoadhesive oral wound rinse, for mucositis, stomatitis, aphthous ulcers, and traumatic ulcers; and ProctiGard, a mucoadhesive oral wound rinse, for the treatment of rectal mucositis and radiation proctitis. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was incorporated in 1989 and is based in Dallas, Texas. http://www.priceseries.com/trade/ABEO-Abeona-Therapeutics-Inc-stock-gains-71-percent-a-Trade-Record-by-priceSeries-2017082320170922.html

XXII 22nd Century Group, Inc gains 27% Sep 21, 2017

22nd Century Group, Inc., a plant biotechnology company, provides technology that allows for the level of nicotine and other nicotinic alkaloids in tobacco plants to be decreased or increased through genetic engineering and plant breeding. It develops smoking cessation products and modified risk tobacco products for smokers who are unable or unwilling to quit smoking and who may be interested in cigarettes, which reduce exposure to nicotine or to certain tobacco smoke toxins and/or pose a lower health risk than conventional cigarettes. The company's products include RED SUN and MAGIC regular and menthol cigarettes; and SPECTRUM government research cigarettes. It is also developing X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy; and modified risk cigarettes, such as BRAND A, which has approximately 95% less nicotine than conventional tobacco cigarettes, as well as BRAND B cigarettes that contain low amount of tar per milligram of nicotine. The company was founded in 1998 and is headquartered in Clarence, New York. http://www.priceseries.com/trade/XXII-22nd-Century-Group-Inc-stock-gains-27-percent-a-Trade-Record-by-priceSeries-2017090720170921.html

WVE WAVE Life Sciences Ltd. gains 23% Sep 21, 2017

WAVE Life Sciences Ltd., a preclinical biopharmaceutical company, designs, develops, and commercializes nucleic acid therapeutic candidates. The company is developing nucleic acid therapeutics that target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. Its advanced therapeutic programs are in Huntington's disease, Duchenne muscular dystrophy (DMD), and inflammatory bowel disease (IBD). In Huntington's disease, it has programs targeting HTT SNP-1 and HTT SNP-2; in DMD, targeting Exon 51; and in IBD, targeting SMAD7. The company also has product candidates in its programs targeting HTT SNP-1 and Exon 51. In addition, it has late-stage discovery programs in epidermolysis bullosa simplex, targeting KRT14 SNP-1 and KRT14 SNP-2, as well as in DMD, focuses on an additional DMD target, AcRIIb. The company has a research, license, and option agreement with Pfizer Inc. for the discovery, development, and commercialization of stereopure oligonucleotide therapeutics. WAVE Life Sciences Ltd. was founded in 2012 and is based in Cambridge, Massachusetts. http://www.priceseries.com/trade/WVE-WAVE-Life-Sciences-Ltd-stock-gains-23-percent-a-Trade-Record-by-priceSeries-2017082520170921.html

WPRT Westport Innovations Inc gains 50% Sep 21, 2017

Westport Fuel Systems Inc. provides low-emission engine and fuel system technologies utilizing gaseous fuels. The company's technology and products enable light, medium, heavy-duty, and high horsepower petroleum-based fuel engines and vehicles to use primarily natural gas and alternative fuels. It designs, manufactures, and sells compressed natural gas, liquefied petroleum gas, and liquefied natural gas (LNG) components and systems to original equipment manufacturers and aftermarket customers. The company also designs and manufactures a range of components, such as pressure regulators, injectors, electronic control units, valves, and filters; sells monofuel, bi-fuel, and dual-fuel diesel blend conversion kits; and offers engine management systems and solutions. In addition, it provides natural gas and propane vehicle conversions through the Ford's qualified vehicle modifier program for Ford vehicles comprising transit, cargo shuttle, and taxi vehicles; and aftermarket conversion products, alternative fuel systems, and application engineering services. Further, the company offers Volvo car bi-fuel systems; Westport JumpStart mobile fuel services; tank systems for spark-ignited engines; LNG tender products for the rail market; and industrial engines for forklift and oilfield applications. Additionally, it provides engines for use in transit, school and shuttle buses, conventional trucks and tractors, and refuse collection trucks, as well as specialty vehicles, such as short-haul port drayage trucks and street sweepers; and develops, manufactures, and sells alternative fuel engines and parts that are used in city bus, coach, and heavy-duty truck applications. The company was formerly known as Westport Innovations Inc. and changed its name to Westport Fuel Systems Inc. in June 2016. The company was founded in 1995 and is headquartered in Vancouver, Canada. http://www.priceseries.com/trade/WPRT-Westport-Innovations-Inc-stock-gains-50-percent-a-Trade-Record-by-priceSeries-2017081120170921.html